Stocks held steady on Tuesday as investors digested earnings reports, with GM soaring 12% after raising its guidance. As earnings season unfolds, all eyes are on Netflix and Tesla's upcoming reports.
After weeks of confusion, Georgia patients can now access the COVID-19 vaccine more easily thanks to finalized recommendations from the CDC, making it simpler to find pharmacies and doctors offering the shot.
The IRS has retracted its earlier guidance promising back pay for furloughed employees, leading to confusion and concern among federal workers as the government shutdown continues.
As the government shutdown continues, the IRS has begun furloughing tens of thousands of employees, raising concerns over back pay and compensation. Legal experts weigh in on the implications for federal workers.
Constellation Brands outperformed expectations in its fiscal Q2 earnings, reporting adjusted earnings of $3.63 per share. However, the company faced challenges with a drop in net sales and reiterated lowered full-year guidance due to macroeconomic issues.
Parents like Remy Sweeney-Garrett are frustrated as CDC delays hinder COVID-19 vaccinations for children. With winter approaching, the lack of guidance raises fears about health risks, especially for vulnerable kids.
As the respiratory season approaches, new guidelines on COVID-19 and flu vaccinations for children are causing confusion. Find out what the latest recommendations say and how to protect your kids this season.
Minnesota's top health official has issued a standing order allowing pharmacists to administer COVID-19 vaccines without prescriptions to a wider patient group, breaking from federal guidelines. This move aims to enhance public access to vaccinations amid the respiratory disease season.
In a decisive move, the Shapiro administration has released new vaccine guidance that diverges from federal recommendations, igniting a debate over public health strategies and insurance coverage for vaccines.
A Seattle doctor reveals that despite changes in the CDC's advisory committee, COVID vaccine access will remain mostly unchanged. Confusion abounds as trust in health institutions wanes.
